 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/15/2024 |
$2.47 |
$2.50 |
$2.29 |
$2.42 |
30.40K | | 04/16/2024 |
$2.36 |
$2.80 |
$2.35 |
$2.50 |
68.60K | | 04/17/2024 |
$2.52 |
$2.55 |
$2.40 |
$2.47 |
15.70K | | 04/18/2024 |
$2.49 |
$2.52 |
$2.39 |
$2.50 |
14.50K | | 04/19/2024 |
$2.50 |
$2.53 |
$2.45 |
$2.48 |
11.40K |
|
|
| Minerva Neurosciences is a clinical-stage biopharmaceutical company focused on the development and commercialization of product candidates to treat patients suffering from central nervous system diseases. Co.'s primary product candidate is roluperidone, a compound it is developing for the treatment of negative symptoms in patients with schizophrenia. Co. holds the license to roluperidone from Mitsubishi Tanabe Pharma Corporation with the rights to develop, sell and import roluperidone globally, excluding most of Asia. Co. also has exclusive rights to develop and commercialize MIN-301, a compound for the treatment of Parkinson's disease. | |
|
Minerva Neurosciences (NERV) has the following price history information. Looking back at NERV historical stock prices for the last five trading days, on April 15, 2024, NERV opened at $2.47, traded as high as $2.50 and as low as $2.29, and closed at $2.42. Trading volume was a total of 30.40K shares. On April 16, 2024, NERV opened at $2.36, traded as high as $2.80 and as low as $2.35, and closed at $2.50. Trading volume was a total of 68.60K shares. On April 17, 2024, NERV opened at $2.52, traded as high as $2.55 and as low as $2.40, and closed at $2.47. Trading volume was a total of 15.70K shares. On April 18, 2024, NERV opened at $2.49, traded as high as $2.52 and as low as $2.39, and closed at $2.50. Trading volume was a total of 14.50K shares. On April 19, 2024, NERV opened at $2.50, traded as high as $2.53 and as low as $2.45, and closed at $2.48. Trading volume was a total of 11.40K shares.
NERV Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Minerva Neurosciences shares, starting with a $10,000 purchase of NERV, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/02/2014 |
|
| End date: |
04/19/2024 |
|
| Start price/share: |
$48.00 |
|
| End price/share: |
$2.48 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-94.83% |
|
| Average Annual Total Return: |
-26.08% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$516.59 |
|
| Years: |
9.81 |
|
|
|
| Date |
Close |
| 04/15/2024 | $2.42 | | 04/16/2024 | $2.50 | | 04/17/2024 | $2.47 | | 04/18/2024 | $2.50 | | 04/19/2024 | $2.48 |
|
|
Free NERV Email Alerts:
